Actinium Pharmaceuticals, Inc. (ATNM)
R&D to Revenue
15.36%
Quarterly · Period ending:
ATNM R&D to Revenue
Latest reported15.36%period ending
Latest reported15.36%period ending
ATNM Quarterly R&D/Revenue (0.00% → 15.36%)
Latest values, visible window
High-resolution chart · PNG
ATNM r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 15.3629% | |
| 0% | |
| 0% | |
| 4,720% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 9,776.5432% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 14,555.5556% | |
| 9,960% | |
| 450.2128% | |
| 22,952.1739% | |
| 2,020.6009% | |
| 1,365.0376% | |
| 687.4598% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -116,135.7341% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |